(Q48118361)

English

Protective effect of imidaprilat, a new angiotensin-converting enzyme inhibitor against 1-methyl-4-phenylpyridinium ion-induced *OH generation in rat striatum

scientific article published in July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

Protective effect of imidaprilat, a new angiotensin-converting enzyme inhibitor against 1-methyl-4-phenylpyridinium ion-induced *OH generation in rat striatum (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

1 reference

based on heuristic

inferred from title

author name string

Obata T

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

378

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

39-45

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

Huntington's chorea: Selective depletion of activity of angiotensin converting enzyme in the corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Subcellular localization and partial purification of a chloride dependent angiotensin-I converting enzyme from rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Different effects of thiol and nonthiol ace inhibitors on copper-induced lipid and protein oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

In vivo autoxidation of dopamine in guinea pig striatum increases with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Interactions of angiotensin II with central dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Angiotensin-converting enzyme in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

The potentiation of cardiodepressant and hypotensive effects of bradykinin by enalapril and captopril both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900450-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2999(99)00450-1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/10478563

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48118361&oldid=2186152234"